2023 annual financial data
Purple Biotech 2023 Operating margin
Purple Biotech 2023 operating margin with verified reported values.
Direct answer
Operating margin was -11,374.13%.
Operating income was -22,271,000 USD and net income was -19,880 USD.
Operating cash flow was -19,925,000 USD.
Get free Purple Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 195,804 USD
- Operating income
- -22,271,000 USD
- Net income
- -19,880 USD
- Operating cash flow
- -19,925,000 USD